-+ 0.00%
-+ 0.00%
-+ 0.00%

MIRUM PHARMACEUTICALS AND INCYTE ANNOUNCE POSITIVE PIVOTAL PHASE 2 RESULTS FROM PROGRESS STUDY OF ZILURGISERTIB IN FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

Reuters·06/14/2026 20:35:00

Please log in to view news